Dáil Éireann Debate, Thursday - 2 July 2026
461. Deputy Pádraig Rice asked the Minister for Health the supports available to residents in an independent living facility, given that they are no longer eligible for blister packs free-of-charge following reforms (details supplied); and if she will make a statement on the matter. [50457/26]
Amharc ar fhreagraFollowing successful negotiations between my Department, the Irish Pharmacy Union and the Health Service Executive, a significant reform of phased dispensing arrangements alongside the introduction of a new patient-centred medicines optimisation support framework came into effect on 1 June 2026.
The reforms are designed to strengthen supports for vulnerable GMS (medical card) patients and will ensure a more robust system. The reforms see rigid phased dispensing fees replaced with a more flexible patient focused model - which empowers pharmacists to use their professional judgment to support patients most in need. It will also reduce administrative burden and further support the profession in the delivery of frontline patient care.
Under these most recent reforms, vulnerable patient groups, who are medical card holders, including those with diagnosed cognitive impairment or dementia, intellectual disability, physical impairment or those patients at risk of medication misuse will now be supported, where appropriate, with a range of tailored supports, free of charge, including:
• adjustments to facilitate use of original packaging.
• medication reminder systems.
• administration charts.
• installment dispensing; and
• blister packs where clinically necessary.
Blister packs will remain a last resort in line with the international evidence due to associated risks including reduced patient autonomy and potential safety concerns. Where clinically required, and deemed appropriate, blister packs will be provided free-of-charge to eligible medical card patients, in identified cohorts.
Importantly, all patients who were receiving phased dispensing or blister packs free-of-charge prior to the Community Pharmacy Agreement 2025 (in August 2025) will continue to do so.
